Chorioamnionitis future or investigational therapies

Chorioamnionitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Chorioamnionitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chorioamnionitis future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chorioamnionitis future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chorioamnionitis future or investigational therapies
CDC on Chorioamnionitis future or investigational therapies
Chorioamnionitis future or investigational therapies in the news
Blogs on Chorioamnionitis future or investigational therapies
Directions to Hospitals Treating Chorioamnionitis
Risk calculators and risk factors for Chorioamnionitis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Future or investigational therapies for clinical chorioamnionitis include administration of vaginal antiseptic solutions and antenatal N-acetylcysteine (NAC).

Future or Investigational Therapies

Future or investigational therapies for clinical chorioamnionitis include:

• Use of antiseptic solutions for vaginal cleansing before the procedure of cesarean section
  • It might decrease the risk of poor infectious outcomes caused by clinical chorioamnionitis during the postoperative period.
• Administration of N‑acetylcysteine (NAC) in patients with clinical chorioamnionitis during the antenatal period
  • It might decrease the morbidity and mortality in neonates exposed to clinical chorioamnionitis.